Procedure: 1
Glycemic control: The SUSTAIN-1 trial demonstrated that semaglutide improved glycemic control, with a mean HbA1c reduction of 2.3% from baseline
Mechanisms of Weight Loss (The Brain and Gut) GLP-1 RAs promote weight loss through a gut-brain axis, acting on receptors in the CNS and gastrointestinal tract to regulate energy balance (Zheng et al., 2024)
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH, also called GRF 1-29)
Whether you're optimizing a liposomal formulation for proof-of-concept studies or preparing for scale-up, BOC Sciences provides the scientific partnership and operational agility you need to move forward with confidence
References Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML